128 related articles for article (PubMed ID: 10882597)
1. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils.
Rose F; Heuer KU; Sibelius U; Hombach-Klonisch S; Kiss L; Seeger W; Grimminger F
J Infect Dis; 2000 Jul; 182(1):191-9. PubMed ID: 10882597
[TBL] [Abstract][Full Text] [Related]
2. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
Vaara M; Viljanen P; Vaara T; Mäkelä PH
J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
[TBL] [Abstract][Full Text] [Related]
3. Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli.
Sahalan AZ; Dixon RA
Int J Antimicrob Agents; 2008 Mar; 31(3):224-7. PubMed ID: 18083010
[TBL] [Abstract][Full Text] [Related]
4. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
Tsubery H; Ofek I; Cohen S; Fridkin M
J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
[TBL] [Abstract][Full Text] [Related]
5. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
Vaara M
Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
[TBL] [Abstract][Full Text] [Related]
6. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
Kim SJ; Jo J; Kim J; Ko KS; Lee W
Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.
Dixon RA; Chopra I
J Antimicrob Chemother; 1986 Nov; 18(5):557-63. PubMed ID: 3027012
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
[TBL] [Abstract][Full Text] [Related]
9. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
Tsubery H; Ofek I; Cohen S; Fridkin M
Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
[TBL] [Abstract][Full Text] [Related]
10. Membrane-disorganizing property of polymyxin B nonapeptide.
Lam C; Hildebrandt J; Schütze E; Wenzel AF
J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
[TBL] [Abstract][Full Text] [Related]
11. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis: VIII. A leukotoxin is produced by Escherichia coli metabolism in hemoglobin.
Pruett TL; Rotstein OD; Fiegel VD; Sorenson JJ; Nelson RD; Simmons RL
Surgery; 1984 Aug; 96(2):375-83. PubMed ID: 6379961
[TBL] [Abstract][Full Text] [Related]
13. Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
McCashion RN; Lynch WH
Antimicrob Agents Chemother; 1987 Sep; 31(9):1414-9. PubMed ID: 2823698
[TBL] [Abstract][Full Text] [Related]
14. Dissociated effect of amphotericin B and desoxycholate on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils.
Lingaas E; Midtvedt T
Drugs Exp Clin Res; 1985; 11(11):747-54. PubMed ID: 3915464
[TBL] [Abstract][Full Text] [Related]
15. The effect of polymyxin B nonapeptide (PMBN) on transformation.
Viljanen P
Biochem Biophys Res Commun; 1987 Mar; 143(3):923-7. PubMed ID: 3032189
[TBL] [Abstract][Full Text] [Related]
16. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.
Dixon RA; Chopra I
Antimicrob Agents Chemother; 1986 May; 29(5):781-8. PubMed ID: 3015004
[TBL] [Abstract][Full Text] [Related]
17. Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B.
Oh JT; Van Dyk TK; Cajal Y; Dhurjati PS; Sasser M; Jain MK
Biochem Biophys Res Commun; 1998 May; 246(3):619-23. PubMed ID: 9618261
[TBL] [Abstract][Full Text] [Related]
18. Binding of polymyxin B nonapeptide to gram-negative bacteria.
Vaara M; Viljanen P
Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
[TBL] [Abstract][Full Text] [Related]
19. Killing of Escherichia coli strains from clinical specimens in human serum and polymorphonuclear leucocytes.
Kumar S; Rizvi M
Indian J Pathol Microbiol; 2002 Apr; 45(2):173-5. PubMed ID: 12696734
[TBL] [Abstract][Full Text] [Related]
20. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
